Intra-Cellular Therapies, Inc.
ITCIDelisted Apr 2, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001567514
Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2021 vs. Q3 2021
How the institutions holding Intra-Cellular Therapies, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 181 | 3 | 208 | +30 |
| Shares | 68.6M | 133.0K | 69.0M | +551.2K (+0.8%) |
| Value | $2.56B | $4.96M | $3.60B | +$1.05B (+41.1%) |
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (52)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (22)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Ikarian Capital, LLC | 211,670 | $7.89M |
| Pura Vida Investments, LLC | 52,213 | $1.95M |
| HRT Financial LP | 39,041 | $1.46M |
| Lazard Asset Management LLC | 31,525 | $1.18M |
| Dynamic Technology Lab Private Ltd | 21,780 | $812.0K |
| Boothbay Fund Management, LLC | 19,851 | $740.0K |
| Tudor Investment Corp Et Al | 18,678 | $696.0K |
| HAP Trading, LLC | 14,460 | $539.0K |
| Old Mission Capital LLC | 12,118 | $452.0K |
| LMR Partners LLP | 12,000 | $447.0K |
| Winton Group Ltd | 11,369 | $424.0K |
| Premier Asset Management LLC | 10,119 | $377.0K |
| Matrix Private Capital Group LLC | 7,800 | $291.0K |
| ExodusPoint Capital Management, LP | 6,859 | $256.0K |
| Sargent Investment Group, LLC | 5,923 | $221.0K |
| Centiva Capital, LP | 5,561 | $207.0K |
| AlphaCentric Advisors LLC | 4,000 | $149.0K |
| Penserra Capital Management LLC | 1,860 | $69.0K |
| Global Retirement Partners, LLC | 863 | $32.0K |
| TD Private Client Wealth LLC | 39 | $1.45K |
| Meridian Wealth Partners, LLC | 20 | $1.00K |
| Harbour Investments, Inc. | 1 | $0 |
Not filed for Q4 2021 yet (3)
Institutions that held Intra-Cellular Therapies, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Sonora Investment Management, LLC | 90,531 | $3.38M |
| B. Metzler seel. Sohn & Co. Holding AG | 42,460 | $1.58M |
| Berman Capital Advisors, LLC | 36 | $1.00K |